Endo Pharmaceuticals recalls

Endo Pharmaceuticals has 5 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 7 Aug 2024.

Total recalls5since 2012

Last 12 months0reported

Class I240% of total

Ongoing0latest 7 Aug 2024

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 2 40%Class II 2 40%Class III 1 20%

Why endo pharmaceuticals is recalled

Product types

Brands

By year

2024120%
2023120%
2018120%
2017120%
2012120%

All endo pharmaceuticals recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
7 Aug 2024Drug	CLASS I	Clonazepam Orally Disintegrating Tablets recalledClonazepam	Endo Pharmaceuticals	Labeling Errors	Nationwide
5 Apr 2023Drug	CLASS II	Calcitonin Salmon Nasal Spray recalled by Endo PharmaceuticalsCalcitonin Salmon	Endo Pharmaceuticals	Potency & Assay	Nationwide
10 Oct 2018Drug	CLASS I	robaxin-750 (methocarbamol tablets, USP), 750 mg recalled	Endo Pharmaceuticals	Other	Nationwide
15 Mar 2017Drug	CLASS II	Edex (alprostadil for injection) 10mcg recalled by Endo PharmaceuticalsEdex	Endo Pharmaceuticals	Sterility	Nationwide
20 Jun 2012Drug	CLASS III	Endocet (oxycodone and acetaminophen) tablets, USP, 10 mg recalled	Endo Pharmaceuticals	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.